Tetramethylpyrazine enhances angiogenesis in diabetic hindlimb ischemia by modulating the THBS1/PI3K/AKT signaling axis and reversing aberrant expression of MFN1/FIS1-related mitochondrial fusion-fission proteins.
[BACKGROUND]: Type 1 diabetes with hindlimb ischemia (T1DM-HLI) is a prevalent diabetic microvascular complication characterized by impaired angiogenesis. Tetramethylpyrazine (TMP) demonstrates therapeutic potential in vascular disorders, but its role in T1DM-HLI remains unclear. [PURPOSE]: This study investigates the...